Literature DB >> 27059725

Food allergen immunotherapy: Current status and prospects for the future.

Robert A Wood1.   

Abstract

Food allergy is a common condition for which the only currently approved treatments are avoidance of the allergenic food and administration of emergency medications on accidental exposure. Over the past 10 years, significant advances have been made in the field of food immunotherapy, including oral immunotherapy, sublingual immunotherapy, and, more recently, epicutaneous immunotherapy. Each of these approaches are intended to induce some level of desensitization with chronic or repeated exposure to the allergenic food protein, although the risks and potential benefits of each treatment differ significantly. Although new data are emerging at a rapid pace and progress has been substantial, a number of important issues need to be addressed before introduction of these therapies into clinical practice. Furthermore, it is entirely possible that advances in this field will render these current approaches obsolete over the next 20 to 30 years as new and better therapies are developed.
Copyright © 2016 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Food allergy; egg allergy; epicutaneous immunotherapy; immunotherapy; milk allergy; omalizumab; oral immunotherapy; peanut allergy; sublingual immunotherapy

Mesh:

Substances:

Year:  2016        PMID: 27059725     DOI: 10.1016/j.jaci.2016.01.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  44 in total

Review 1.  The Current State of Epicutaneous Immunotherapy for Food Allergy: a Comprehensive Review.

Authors:  Bruce J Lanser; Donald Y M Leung
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

2.  Long-Term Follow-Up After Baked Milk Introduction.

Authors:  Joan H Dunlop; Corinne A Keet; Kim Mudd; Robert A Wood
Journal:  J Allergy Clin Immunol Pract       Date:  2018-03-02

Review 3.  Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.

Authors:  Amy M Scurlock
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

Review 4.  Update on Potential Therapies for IgE-Mediated Food Allergy.

Authors:  Andrew MacGinnite
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.806

Review 5.  The current state of food allergy therapeutics.

Authors:  Meng Chen; Michael Land
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

6.  Effect of Varying Doses of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Exposure Among Patients With Peanut Sensitivity: A Randomized Clinical Trial.

Authors:  Hugh A Sampson; Wayne G Shreffler; William H Yang; Gordon L Sussman; Terri F Brown-Whitehorn; Kari C Nadeau; Amarjit S Cheema; Stephanie A Leonard; Jacqueline A Pongracic; Christine Sauvage-Delebarre; Amal H Assa'ad; Frederic de Blay; J Andrew Bird; Stephen A Tilles; Franck Boralevi; Thierry Bourrier; Jacques Hébert; Todd D Green; Roy Gerth van Wijk; André C Knulst; Gisèle Kanny; Lynda C Schneider; Marek L Kowalski; Christophe Dupont
Journal:  JAMA       Date:  2017-11-14       Impact factor: 56.272

Review 7.  Immune mechanisms of oral immunotherapy.

Authors:  Michael D Kulis; Sarita U Patil; Erik Wambre; Brian P Vickery
Journal:  J Allergy Clin Immunol       Date:  2017-12-26       Impact factor: 10.793

Review 8.  IL-9-producing cells in the development of IgE-mediated food allergy.

Authors:  Dana Shik; Sunil Tomar; Jee-Boong Lee; Chun-Yu Chen; Andrew Smith; Yui-Hsi Wang
Journal:  Semin Immunopathol       Date:  2016-12-01       Impact factor: 9.623

9.  CD33 recruitment inhibits IgE-mediated anaphylaxis and desensitizes mast cells to allergen.

Authors:  Shiteng Duan; Cynthia J Koziol-White; William F Jester; Scott A Smith; Corwin M Nycholat; Matthew S Macauley; Reynold A Panettieri; James C Paulson
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

Review 10.  Eosinophilic esophagitis during sublingual and oral allergen immunotherapy.

Authors:  Joseph Cafone; Peter Capucilli; David A Hill; Jonathan M Spergel
Journal:  Curr Opin Allergy Clin Immunol       Date:  2019-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.